**2 Door **super Rare** L@@k!! ~low~ Reserve! Last Time I Am Listing On Ebay** on 2040-cars

Auto blog

Investors want answers about Marchionne’s final days

The mystery of Sergio Marchionne's surprise death last week continues, with investors now questioning the timeliness of disclosures by the company and family. Bloomberg reports that Italy's market regulator is making a routine check into how Fiat Chrysler handled communications regarding his illness. Fiat Chrysler's stock is down 12 percent in both Italy and on the New York Stock Exchange since the announcement of Marchionne's death. University Hospital Zurich last week issued a statement saying that Marchionne, who died July 25 while recovering from an unspecified should surgery, had been treated for more than a year for a serious illness that it didn't define. Marchionne's family told Reuters the companies hadn't been aware of his health conditions. The Italian business website Lettera 43 reported July 5, and FCA later confirmed, that Marchionne had undergone shoulder surgery in a Swiss hospital. But the company later denied a July 20 report by the website that Fiat Chairman John Elkann planned to meet with company leaders to divide Marchionne's responsibilities. Yet the FCA board indeed met on July 21 and chose Mike Manley, who had formerly overseen the Jeep and Ram brands, to succeed Marchionne as CEO. The company on July 25 published a brief statement acknowledging the former CEO's death. "Unfortunately, what we feared has come to pass. Sergio Marchionne, man and friend, is gone," Elkann said in the statement. Marchionne told no one outside his inner circle — reportedly not even Elkann — that he was seriously ill. His partner, Manuela Battezzato, who works in Fiat's press department, told Bloomberg that Marchionne's family didn't tell the company about his health condition. The famously hard-working CEO, who had quit smoking about a year ago, had also reportedly stopped responding to messages and calls from some advisors since the end of June. People close to him told Bloomberg that Marchionne died from complications following the shoulder surgery, including two cardiac arrests. Image Credit: Ferrari flags hang at half-staff at the Hungarian Grand Prix / Getty Chrysler Fiat Sergio Marchionne

FCA registers 'Cuda' trademark, but we wouldn't get our hopes up

It seems Chrysler has submitted a trademark with the US Patent and Trademark Office for the name "Cuda," as first reported by Motor1. Fans of Mopar will instantly recognize this as the abbreviated name of Plymouth's classic Barracuda muscle car, which occasionally bared the shortened nomenclature. Though this might seem like a sign that FCA is considering a revival of the beloved machine, we wouldn't get our hopes up. See, rumors of a 'Cuda or Barracuda revival have circulated pretty much since the moment Dodge showed the modern Challenger and when it went on sale. And some of those rumors have involved the re-registering of the 'Cuda trademark, even as far back as 2010. Over the years, each rumor died a quiet death as time went on and no 'Cudas appeared on dealer lots. There is one rumor that's recent enough to still have a slim chance of realization, circa 2015 to be exact. It predicts a smaller Challenger-based car called Barracuda that could appear as a Dodge in both coupe and drop-top versions. However, we doubt it will come true, since FCA doesn't exactly have a large development budget, and we're not sure what the company would have to gain by making another sports car to sell below the Challenger. Odds are, it would cannibalize sales from the older, completely developed, and thus more profitable Challenger. Really, this trademark filing is probably just a defensive move for Chrysler. It will ensure that no one else can slip in and snag the name for their own vehicle. It should also help ensure that Chrysler has the rights to use the name on other products such as memorabilia. Sorry to crush your dreams. Related Video: News Source: US Patent and Trademark Office via Motor1Image Credit: Chrysler Rumormill Chrysler Dodge Coupe Performance hemi cuda

Stellantis is official: FCA and PSA merger finally sealed

MILAN — Fiat Chrysler and PSA sealed their long-awaited merger on Saturday to create Stellantis, the world's fourth-largest auto group with deep enough pockets to fund the shift to electric driving and take on bigger rivals Toyota and Volkswagen. It took over a year for the Italian-American and French automakers to finalize the $52 billion deal, during which the global economy was upended by the COVID-19 pandemic. They first announced plans to merge in October 2019, to create a group with annual sales of around 8.1 million vehicles. "The merger between Peugeot S.A. and Fiat Chrysler Automobiles N.V. that will lead the path to the creation of Stellantis N.V. became effective today," the two automakers said in a statement. Shares in Stellantis, which will be headed by current PSA Chief Executive Carlos Tavares, will start trading in Milan and Paris on Monday, and in New York on Tuesday. Now analysts and investors are turning their focus to how Tavares plans to address the huge challenges facing the group – from excess production capacity to a woeful performance in China. Tavares will hold his first press conference as Stellantis CEO on Tuesday, after ringing NYSE's bell with Chairman John Elkann. FCA and PSA have said Stellantis can cut annual costs by over 5 billion euros ($6.1 billion) without plant closures, and investors will be keen for more details on how it will do this. Marco Santino, a partner at consultants Oliver Wyman, said he expected Tavares to disclose the outlines of his action plan soon, but without divulging too many details at first. "He has proven to be the kind of person who prefers action to words, so I don't think he will make loud statements or try to over-sell targets," he said. Like all global automakers, Stellantis needs to invest billions in the years ahead to transform its vehicle range for the electric era. But other pressing tasks loom, including reviving the group's lagging fortunes in China, rationalizing its huge global empire and addressing massive overcapacity. "It will be a step by step process, also to allow the market to better appreciate every single move. I don't think we will have all the details before one year," Santino said.